News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bacchus Vascular, Inc. Announces The U.S. Clearance For The TRELLIS-8 Isolated Thrombolysis Catheter


10/19/2005 5:13:09 PM

SANTA CLARA, Calif.--(BUSINESS WIRE)--March 28, 2005--Bacchus Vascular, Inc. announces the recent U.S. Food and Drug Administration (FDA) clearance of the TRELLIS(R)-8 Peripheral Infusion System. The TRELLIS-8 is an advanced drug infusion catheter designed for the treatment of Deep Vein Thrombosis (DVT) and Arterial Occlusions by enabling targeted delivery of clot-dissolving drugs. The TRELLIS-8 clearance is for the infusion of physician specified fluids, including thrombolytics, into the peripheral vasculature. "Interventionalists are demanding a tool to treat DVT efficiently and cost-effectively," said Dr. Thomas Fogarty, Stanford cardiovascular surgeon and founder of Bacchus Vascular. "Our engineers designed the TRELLIS-8 to treat DVT in a single procedure and not require a hospital to invest in capital equipment."

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES